Cellular and humoral antigenic epitopes in HIV and SIV.
作者信息
Nixon D F, Broliden K, Ogg G, Broliden P A
出版信息
Immunology. 1992 Aug;76(4):515-34.
Abstract
摘要
相似文献
1
Cellular and humoral antigenic epitopes in HIV and SIV.HIV和SIV中的细胞和体液抗原表位
Immunology. 1992 Aug;76(4):515-34.
2
Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV.1型人类免疫缺陷病毒、2型人类免疫缺陷病毒和猴免疫缺陷病毒之间共有的细胞毒性T淋巴细胞表位
J Med Primatol. 1993 Feb-May;22(2-3):119-23.
3
Cytotoxic T-cell epitopes in HIV/SIV infection.HIV/SIV感染中的细胞毒性T细胞表位
AIDS. 1993;7 Suppl 1:S117-26.
4
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.在原发性病毒血症消退期间，针对Tat的细胞毒性T淋巴细胞会选择SIV逃逸变体。
Nature. 2000 Sep 21;407(6802):386-90. doi: 10.1038/35030124.
5
HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.来自免疫灵长类动物的HIV p24特异性辅助性T细胞克隆识别HIV-1的高度保守区域。
J Immunol. 1990 Mar 1;144(5):1677-83.
6
Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.接种疫苗的猕猴血清中的抗细胞抗体可诱导补体介导的人免疫缺陷病毒和猴免疫缺陷病毒的病毒溶解。
Virology. 1993 Aug;195(2):475-80. doi: 10.1006/viro.1993.1398.
7
Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.用于在SHIV猴模型中进行比较评估的重组病毒样颗粒和塞姆利基森林病毒活载体的构建与表征。
Biol Chem. 1999 Mar;380(3):341-52. doi: 10.1515/BC.1999.046.
8
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.猕猴脂肽免疫和猴免疫缺陷病毒攻击后Nef表位细胞毒性T淋巴细胞识别的暂时丧失
Virology. 2000 Dec 20;278(2):551-61. doi: 10.1006/viro.2000.0671.
9
引用本文的文献
1
Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes.针对HIV-1 gp120可变环表位的交叉亚型疫苗。
Vaccine. 2014 Sep 3;32(39):4916-24. doi: 10.1016/j.vaccine.2014.07.026. Epub 2014 Jul 18.
2
A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity.HIV-1 抗体 2G12 的二聚体形式可引发有效的抗体依赖性细胞细胞毒性。
AIDS. 2010 Jul 17;24(11):1633-40. doi: 10.1097/qad.0b013e32833ad8c8.
3
Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.长期间隔黏膜初免-全身加强免疫诱导的全身中和抗体与抵抗黏膜SHIV攻击的保护作用相关。
Virology. 2008 Dec 20;382(2):217-25. doi: 10.1016/j.virol.2008.09.016. Epub 2008 Oct 22.
4
Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.艾滋病患者中人类免疫缺陷病毒（HIV）特异性感染增强抗体与抑制抗体的比较。
J Clin Microbiol. 2002 Jun;40(6):2141-6. doi: 10.1128/JCM.40.6.2141-2146.2002.
5
Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection.抗体依赖性细胞毒性介导的抗HIV-1抗体与HIV感染预后预测指标之间相关性的证据。
J Clin Immunol. 2001 May;21(3):227-33. doi: 10.1023/a:1011087132180.
6
Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes.CD8 + T淋巴细胞分泌的可溶性因子在体外对猫免疫缺陷病毒复制的抑制作用。
Immunology. 1999 Feb;96(2):220-9. doi: 10.1046/j.1365-2567.1999.00690.x.
7
Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.gp120和gp41中的突变导致了1型变异人类免疫缺陷病毒MN对针对V3和非V3表位的抗体产生广泛的中和抗性。
J Virol. 1998 Sep;72(9):7099-107. doi: 10.1128/JVI.72.9.7099-7107.1998.
8
T-cells and macrophages in HIV disease.HIV疾病中的T细胞和巨噬细胞。
Clin Rev Allergy Immunol. 1996;14(4):359-66. doi: 10.1007/BF02771752.
9
Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.I类HLA限制的抗疟疾细胞毒性T淋巴细胞反应——基于HLA肽结合基序的阐释
Immunol Res. 1996;15(4):280-305. doi: 10.1007/BF02935313.
10
Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection.猫免疫缺陷病毒疫苗接种：保护性免疫相关因素的特征分析
J Virol. 1996 Nov;70(11):7561-8. doi: 10.1128/JVI.70.11.7561-7568.1996.
本文引用的文献
1
Cytotoxic T-cell immunity to influenza.针对流感的细胞毒性T细胞免疫
N Engl J Med. 1983 Jul 7;309(1):13-7. doi: 10.1056/NEJM198307073090103.
2
3
Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus.在人类免疫缺陷病毒跨膜蛋白中检测融合肽序列
Cell. 1987 Jul 31;50(3):327-8. doi: 10.1016/0092-8674(87)90485-5.
4
AIDS virus-specific cytotoxic T lymphocytes in lung disorders.肺部疾病中的艾滋病病毒特异性细胞毒性T淋巴细胞
Nature. 1987;328(6128):348-51. doi: 10.1038/328348a0.
5
HIV-specific cytotoxic T lymphocytes in seropositive individuals.血清反应阳性个体中的HIV特异性细胞毒性T淋巴细胞。
Nature. 1987;328(6128):345-8. doi: 10.1038/328345a0.
6
Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus.
J Infect Dis. 1987 Dec;156(6):878-84. doi: 10.1093/infdis/156.6.878.
7
Induction of anti-HIV neutralizing antibodies by synthetic peptides.合成肽诱导抗HIV中和抗体
EMBO J. 1986 Nov;5(11):3065-71. doi: 10.1002/j.1460-2075.1986.tb04607.x.
8
Type-restricted neutralization of molecular clones of human immunodeficiency virus.人免疫缺陷病毒分子克隆的型特异性中和作用
Science. 1988 Jul 15;241(4863):357-9. doi: 10.1126/science.3388046.
9
10
Structure of the human class I histocompatibility antigen, HLA-A2.人类I类组织相容性抗原HLA - A2的结构
Nature. 1987;329(6139):506-12. doi: 10.1038/329506a0.
Zotero 插件